Most Neurologists Plan To Prescribe Oral Multiple Sclerosis Drugs, But Will Proceed With Caution
Source: Medical News Today
Friday 3rd September, 2010
In a study published this week by Majestic Research, almost 60% of neurologists expressed unaided concern about the side effects/safety of oral MS therapies in development, including NVS's Gilenia and... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story